REQUEST A DEMO
Total
USD $0.00
Search more companies

"Novo Nordisk Pharma" Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | All Other Professional, Scientific, and Technical Services | Convention and Trade Show Organizers | Educational Services
Full name: "Novo Nordisk Pharma" Sp. z o.o. Profile Updated: March 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

"Novo Nordisk Pharma" Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The company was established on February 18, 2002. 24 (2021) employees currently work for "Novo Nordisk Pharma" Sp. z o.o.. From the latest financial highlights, "Novo Nordisk Pharma" Sp. z o.o. reported a net sales revenue increase of 26.55% in 2024. During that time, "Novo Nordisk Pharma" Sp. z o.o.’s total assets grew by 44.05%. The enterprise’s net profit margin increased by 6.89% in 2024.

Headquarters
Ul. Krakowiakow 46
Warsaw; Mazowieckie; Postal Code: 02-255

Contact Details: Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.

Website: http://www.novonordisk.pl

Basic Information
Total Employees:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Novo Nordisk Pharma" Sp. z o.o. report to view the information.
Incorporation Date:
February 18, 2002
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after "Novo Nordisk Pharma" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
26.55%
Total Operating Revenue
26.41%
Operating Profit
24.36%
EBITDA
24.3%
Net Profit/Loss for the Period
218.16%
Total Assets
44.05%
Total Equity
84.04%
Operating Profit Margin
-0.11%
Net Profit Margin
6.89%
Return on Equity (ROE)
19.25%
Quick Ratio
0.32%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?